Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography.

Positron emission tomography offers the ability to noninvasively assess regional myocardial perfusion in absolute terms (i.e., milliliters per gram per minute). Accurate estimates have been difficult to achieve with generator-produced 82Rb because of the complex behavior of this tracer in the myocardium. The aim of the present study was to determine whether regional myocardial blood flow could be assessed quantitatively with 82Rb and positron emission tomography by using a two-compartment kinetic model. Regional perfusion in milliliters per gram per minute was estimated from dynamic tomographic scans after intravenous administration of 82Rb in 18 studies in 13 intact dogs studied without intervention, after 2 and 24 hours of induced ischemia, during reperfusion after transient occlusion, or at rest and after pharmacological hyperemia after induced coronary artery stenosis. Regional flow was estimated along with the forward and backward rates of transport (k1 and k2 [minutes-1]) after the relative volume of distribution of the first compartment was fixed to 0.53 ml/ml and the tomographic parameters, the recovery and spillover fractions, were fixed to averaged values obtained in previous studies. In 36 comparisons, estimates of regional flow with 82Rb correlated well with flow measured with concomitantly administered radiolabeled microspheres (r = 0.91, p less than 0.05) over the flow range from 0.14 to 4.25 ml/g/min. A putative index of viability, k2, increased significantly in regions with severe ischemia. The results suggest that quantification of regional myocardial perfusion is possible in centers using 82Rb for estimates of myocardial perfusion when a physiologically appropriate, two-compartment model is used.

[1]  B E Sobel,et al.  Positron emission tomography of the heart. , 1992, Progress in cardiovascular diseases.

[2]  Adriaan A. Lammertsma,et al.  Noninvasive Quantification of Regional Myocardial Blood Flow in Coronary Artery Disease With Oxygen‐15–Labeled Carbon Dioxide Inhalation and Positron Emission Tomography , 1991, Circulation.

[3]  P. Herrero,et al.  Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. , 1990, Circulation.

[4]  D E Kuhl,et al.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.

[5]  M E Phelps,et al.  13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.

[6]  M. Walsh,et al.  Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. , 1989, Journal of the American College of Cardiology.

[7]  P. Herrero,et al.  Quantitation of myocardial blood flow with H2 15O and positron emission tomography: assessment and error analysis of a mathematical approach. , 1989, Journal of computer assisted tomography.

[8]  M E Phelps,et al.  Rabbit myocardial 82Rb kinetics and a compartmental model for blood flow estimation. , 1989, The American journal of physiology.

[9]  N. Mullani,et al.  Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. , 1989, Circulation.

[10]  Steven R. Bergmann,et al.  Measurement of myocardial blood flow with positron emission tomography: Correction for count spillover and partial volume effects , 1988 .

[11]  F Shishido,et al.  Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. , 1988, Circulation.

[12]  N. Mullani,et al.  Changes in myocardial perfusion reserve after PTCA: noninvasive assessment with positron tomography. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  N. Mullani,et al.  Skeletal muscle blood flow in vivo: detection with rubidium-82 and effects of glucose, insulin, and exercise. , 1987, Journal of Nuclear Medicine.

[14]  R. A. Goldstein Rubidium-82 kinetics after coronary occlusion: temporal relation of net myocardial accumulation and viability in open-chested dogs. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  N. Mullani,et al.  Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82. , 1986, Journal of the American College of Cardiology.

[16]  E. Hoffman,et al.  Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  B. Sobel,et al.  Characterization of the functional significance of subcritical coronary stenoses with H(2)15O and positron-emission tomography. , 1985, Circulation.

[18]  R. A. Goldstein Kinetics of rubidium-82 after coronary occlusion and reperfusion. Assessment of patency and viability in open-chested dogs. , 1985, The Journal of clinical investigation.

[19]  M J Welch,et al.  Quantification of regional myocardial blood flow in vivo with H2150* , 2005 .

[20]  M E Phelps,et al.  Measurements of regional tissue and blood-pool radiotracer concentrations from serial tomographic images of the heart. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  H A O'Brien,et al.  Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  N. Mullani,et al.  Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  M. Ter-pogossian,et al.  Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. , 1982, The American journal of medicine.

[24]  A. Kuroiwa,et al.  Reduced reflow and diminished uptake of 86Rb after temporary coronary occlusion. , 1978, The American journal of physiology.

[25]  J I Hoffman,et al.  Blood flow measurements with radionuclide-labeled particles. , 1977, Progress in cardiovascular diseases.

[26]  C. Goresky,et al.  Kinetics of Rubidium Uptake in the Working Dog Heart , 1971, Circulation research.

[27]  R. Bing,et al.  The Determination of Coronary Flow Equivalent with Coincidence Counting Technic , 1964, Circulation.

[28]  N. Mullani,et al.  Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  A. Lammertsma,et al.  Rubidium-82 myocardial uptake and extraction after transient ischemia: PET characteristics. , 1987, Journal of computer assisted tomography.

[30]  R. Bing,et al.  Measurement of coronary blood flow using rubidium-84 and the coincidence counting method. A critical analysis. , 1967, The American journal of cardiology.

[31]  R. Bing,et al.  Myocardial extraction of Rb-86 in the rabbit. , 1959, The American journal of physiology.